Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was incremented from v3.6.4 to v3.6.5, indicating a minor update to the page. No visible content changes are indicated by this revision bump.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision label was updated to v3.6.4, replacing the previous v3.6.3. This signals a new version of the page content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor system update.SummaryDifference0.0%

- Check51 days agoChange DetectedAn updated study overview was added, detailing the evaluation of avutometinib and defactinib for RAF dimer-driven thyroid cancers and the safety profile. The FDA OOPD funding line was added, and the previous version of the description and its revision notes was removed.SummaryDifference0.3%

- Check66 days agoChange DetectedNew quick links were added to the Study Details page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study), and the label for Intervention/Treatment was adjusted. The version tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check73 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This reflects a minor update to the published page without altering the study content.SummaryDifference0.1%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.